2023-04-012024-03-312024-03-31false12618677EOG HOLDINGS LTD2024-07-25iso4217:GBPxbrli:pure126186772023-04-01126186772024-03-31126186772023-04-012024-03-31126186772022-04-01126186772023-03-31126186772022-04-012023-03-3112618677bus:SmallEntities2023-04-012024-03-3112618677bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3112618677bus:FullAccounts2023-04-012024-03-3112618677bus:PrivateLimitedCompanyLtd2023-04-012024-03-3112618677core:WithinOneYear2024-03-3112618677core:AfterOneYear2024-03-3112618677core:WithinOneYear2023-03-3112618677core:AfterOneYear2023-03-3112618677core:ShareCapital2024-03-3112618677core:SharePremium2024-03-3112618677core:RevaluationReserve2024-03-3112618677core:OtherReservesSubtotal2024-03-3112618677core:RetainedEarningsAccumulatedLosses2024-03-3112618677core:ShareCapital2023-03-3112618677core:SharePremium2023-03-3112618677core:RevaluationReserve2023-03-3112618677core:OtherReservesSubtotal2023-03-3112618677core:RetainedEarningsAccumulatedLosses2023-03-3112618677core:LandBuildings2024-03-3112618677core:PlantMachinery2024-03-3112618677core:Vehicles2024-03-3112618677core:FurnitureFittings2024-03-3112618677core:OfficeEquipment2024-03-3112618677core:NetGoodwill2024-03-3112618677core:IntangibleAssetsOtherThanGoodwill2024-03-3112618677core:ListedExchangeTraded2024-03-3112618677core:UnlistedNon-exchangeTraded2024-03-3112618677core:LandBuildings2023-03-3112618677core:PlantMachinery2023-03-3112618677core:Vehicles2023-03-3112618677core:FurnitureFittings2023-03-3112618677core:OfficeEquipment2023-03-3112618677core:NetGoodwill2023-03-3112618677core:IntangibleAssetsOtherThanGoodwill2023-03-3112618677core:ListedExchangeTraded2023-03-3112618677core:UnlistedNon-exchangeTraded2023-03-3112618677core:LandBuildings2023-04-012024-03-3112618677core:PlantMachinery2023-04-012024-03-3112618677core:Vehicles2023-04-012024-03-3112618677core:FurnitureFittings2023-04-012024-03-3112618677core:OfficeEquipment2023-04-012024-03-3112618677core:NetGoodwill2023-04-012024-03-3112618677core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112618677core:ListedExchangeTraded2023-04-012024-03-3112618677core:UnlistedNon-exchangeTraded2023-04-012024-03-3112618677core:MoreThanFiveYears2023-04-012024-03-3112618677core:Non-currentFinancialInstruments2024-03-3112618677core:Non-currentFinancialInstruments2023-03-3112618677dpl:CostSales2023-04-012024-03-3112618677dpl:DistributionCosts2023-04-012024-03-3112618677core:LandBuildings2023-04-012024-03-3112618677core:PlantMachinery2023-04-012024-03-3112618677core:Vehicles2023-04-012024-03-3112618677core:FurnitureFittings2023-04-012024-03-3112618677core:OfficeEquipment2023-04-012024-03-3112618677dpl:AdministrativeExpenses2023-04-012024-03-3112618677core:NetGoodwill2023-04-012024-03-3112618677core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112618677dpl:GroupUndertakings2023-04-012024-03-3112618677dpl:ParticipatingInterests2023-04-012024-03-3112618677dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112618677core:ListedExchangeTraded2023-04-012024-03-3112618677dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112618677core:UnlistedNon-exchangeTraded2023-04-012024-03-3112618677dpl:CostSales2022-04-012023-03-3112618677dpl:DistributionCosts2022-04-012023-03-3112618677core:LandBuildings2022-04-012023-03-3112618677core:PlantMachinery2022-04-012023-03-3112618677core:Vehicles2022-04-012023-03-3112618677core:FurnitureFittings2022-04-012023-03-3112618677core:OfficeEquipment2022-04-012023-03-3112618677dpl:AdministrativeExpenses2022-04-012023-03-3112618677core:NetGoodwill2022-04-012023-03-3112618677core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3112618677dpl:GroupUndertakings2022-04-012023-03-3112618677dpl:ParticipatingInterests2022-04-012023-03-3112618677dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3112618677core:ListedExchangeTraded2022-04-012023-03-3112618677dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3112618677core:UnlistedNon-exchangeTraded2022-04-012023-03-3112618677core:NetGoodwill2024-03-3112618677core:IntangibleAssetsOtherThanGoodwill2024-03-3112618677core:LandBuildings2024-03-3112618677core:PlantMachinery2024-03-3112618677core:Vehicles2024-03-3112618677core:FurnitureFittings2024-03-3112618677core:OfficeEquipment2024-03-3112618677core:AfterOneYear2024-03-3112618677core:WithinOneYear2024-03-3112618677core:ListedExchangeTraded2024-03-3112618677core:UnlistedNon-exchangeTraded2024-03-3112618677core:ShareCapital2024-03-3112618677core:SharePremium2024-03-3112618677core:RevaluationReserve2024-03-3112618677core:OtherReservesSubtotal2024-03-3112618677core:RetainedEarningsAccumulatedLosses2024-03-3112618677core:NetGoodwill2023-03-3112618677core:IntangibleAssetsOtherThanGoodwill2023-03-3112618677core:LandBuildings2023-03-3112618677core:PlantMachinery2023-03-3112618677core:Vehicles2023-03-3112618677core:FurnitureFittings2023-03-3112618677core:OfficeEquipment2023-03-3112618677core:AfterOneYear2023-03-3112618677core:WithinOneYear2023-03-3112618677core:ListedExchangeTraded2023-03-3112618677core:UnlistedNon-exchangeTraded2023-03-3112618677core:ShareCapital2023-03-3112618677core:SharePremium2023-03-3112618677core:RevaluationReserve2023-03-3112618677core:OtherReservesSubtotal2023-03-3112618677core:RetainedEarningsAccumulatedLosses2023-03-3112618677core:NetGoodwill2022-04-0112618677core:IntangibleAssetsOtherThanGoodwill2022-04-0112618677core:LandBuildings2022-04-0112618677core:PlantMachinery2022-04-0112618677core:Vehicles2022-04-0112618677core:FurnitureFittings2022-04-0112618677core:OfficeEquipment2022-04-0112618677core:AfterOneYear2022-04-0112618677core:WithinOneYear2022-04-0112618677core:ListedExchangeTraded2022-04-0112618677core:UnlistedNon-exchangeTraded2022-04-0112618677core:ShareCapital2022-04-0112618677core:SharePremium2022-04-0112618677core:RevaluationReserve2022-04-0112618677core:OtherReservesSubtotal2022-04-0112618677core:RetainedEarningsAccumulatedLosses2022-04-0112618677core:AfterOneYear2023-04-012024-03-3112618677core:WithinOneYear2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112618677core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112618677core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112618677core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3112618677core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3112618677core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3112618677bus:Director12023-04-012024-03-3112618677bus:Director22023-04-012024-03-31

EOG HOLDINGS LTD

Registered Number
12618677
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

EOG HOLDINGS LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

GODFREY, Oliver John, Dr
OSBORNE, Emily Kate, Dr

Registered Address

8 Hartington Road
Buxton
SK17 6JW

Registered Number

12618677 (England and Wales)
EOG HOLDINGS LTD
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets311
Tangible assets4138,500138,500
138,501138,501
Current assets
Cash at bank and on hand867285
867285
Creditors amounts falling due within one year5(67,613)(67,683)
Net current assets (liabilities)(66,746)(67,398)
Total assets less current liabilities71,75571,103
Creditors amounts falling due after one year6(96,192)(93,522)
Net assets(24,437)(22,419)
Capital and reserves
Called up share capital200200
Profit and loss account(24,637)(22,619)
Shareholders' funds(24,437)(22,419)
The financial statements were approved and authorised for issue by the Board of Directors on 25 July 2024, and are signed on its behalf by:
GODFREY, Oliver John, Dr
Director
OSBORNE, Emily Kate, Dr
Director

Registered Company No. 12618677
EOG HOLDINGS LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
2.Average number of employees

20242023
Average number of employees during the year00
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 2311
At 31 March 2411
Net book value
At 31 March 2411
At 31 March 2311
4.Tangible fixed assets

Land & buildings

Total

££
Cost or valuation
At 01 April 23138,500138,500
At 31 March 24138,500138,500
Net book value
At 31 March 24138,500138,500
At 31 March 23138,500138,500
5.Creditors: amounts due within one year

2024

2023

££
Bank borrowings and overdrafts1,7826,234
Amounts owed to related parties64,75260,369
Accrued liabilities and deferred income1,0791,080
Total67,61367,683
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts96,19293,522
Total96,19293,522
7.Related party transactions
At the year end the company owed the directors £59,479.09 (2023: £56,310), this balance is included within creditors. Interest was charged at market rate on the loan which is repayable on demand.